Skip to content

Clinical trials

Rectal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Country / region: United States Clear all

776 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200032
200140
200222
200333
200428
200534
200641
200728
200827
200933
201037
201129
201218
201327
201421
201515
201619
201717
201816
201923
202031
202123
202232
202319
202419
202513
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed454
Terminated128
Recruiting76
Active, not recruiting54
Unknown status31
Withdrawn24
Not yet recruiting6
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)87
Memorial Sloan Kettering Cancer Center54
Alliance for Clinical Trials in Oncology31
City of Hope Medical Center25
M.D. Anderson Cancer Center23
Fox Chase Cancer Center17
Case Comprehensive Cancer Center16
Roswell Park Cancer Institute15
Stanford University14
Ohio State University Comprehensive Cancer Center13

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms776
Colonic Neoplasms556
Colorectal Neoplasms382
Pancreatic Neoplasms101
Breast Neoplasms90
Stomach Neoplasms75
Carcinoma, Non-Small-Cell Lung65
Lung Neoplasms60
Neoplasm Metastasis58
Neoplasms57

Trials

Showing 76 to 100 of 776. Each trial links to its page on Pharma Observatory.

676 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.